Tavira Therapeutics

Tavira Therapeutics is developing a modular AAV capsid platform to enhance tissue-specific transgene delivery for gene therapy applications. This technology aims to improve the precision and efficacy of gene therapies by targeting specific tissues, thereby increasing therapeutic outcomes.

Traction 4/10

London, United Kingdom · HQ

Founded 20236300+ followers

Biotechnology

Updated 6 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

2 founders

Benjamien Moeyaert

Co-founder / Platform Lead

Els Henckaerts

Co-founder

Product

Features

Tavira Therapeutics is developing a modular AAV capsid platform to enhance tissue-specific transgene delivery for gene therapy applications. This technology aims to improve the precision and efficacy of gene therapies by targeting specific tissues, thereby increasing therapeutic outcomes.